Latest Insider Transactions at Denali Therapeutics Inc. (DNLI)
This section provides a real-time view of insider transactions for Denali Therapeutics Inc. (DNLI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Denali Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Denali Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2025
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,907
-1.18%
|
$58,140
$20.81 P/Share
|
|
Jan 07
2025
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,907
-1.63%
|
$58,140
$20.81 P/Share
|
|
Jan 07
2025
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
3,339
-11.48%
|
$66,780
$20.81 P/Share
|
|
Jan 07
2025
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
7,650
-2.93%
|
$153,000
$20.81 P/Share
|
|
Jan 06
2025
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
12,255
-4.72%
|
$245,100
$20.22 P/Share
|
|
Jan 06
2025
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,255
-6.42%
|
$245,100
$20.22 P/Share
|
|
Jan 06
2025
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
29,266
-10.09%
|
$585,320
$20.22 P/Share
|
|
Jan 03
2025
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,180
+22.11%
|
-
|
|
Jan 03
2025
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
54,180
+17.27%
|
-
|
|
Jan 03
2025
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
54,180
+15.74%
|
-
|
|
Jan 02
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,080
-2.77%
|
$61,600
$20.91 P/Share
|
|
Dec 31
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
30,000
-50.76%
|
$600,000
$20.25 P/Share
|
|
Dec 27
2024
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,708
+3.16%
|
$33,540
$5.28 P/Share
|
|
Nov 25
2024
|
Carole Ho Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,845
+11.55%
|
$0
$0.68 P/Share
|
|
Nov 22
2024
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
20,516
+9.36%
|
$0
$0.68 P/Share
|
|
Nov 11
2024
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
59,441
-58.66%
|
$1,902,112
$32.48 P/Share
|
|
Nov 11
2024
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
47,165
+40.72%
|
$848,970
$18.0 P/Share
|
|
Nov 07
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
15,558
-2.72%
|
$466,740
$30.56 P/Share
|
|
Nov 07
2024
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
15,558
+7.44%
|
$77,790
$5.28 P/Share
|
|
Nov 07
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,020
-0.91%
|
$30,600
$30.0 P/Share
|
|
Nov 01
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,080
-2.67%
|
$83,160
$27.07 P/Share
|
|
Oct 18
2024
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-14.5%
|
$1,080,000
$27.69 P/Share
|
|
Oct 18
2024
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+12.67%
|
$0
$0.68 P/Share
|
|
Sep 30
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
30,000
-50.76%
|
$870,000
$29.03 P/Share
|
|
Sep 13
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,020
-0.88%
|
$30,600
$30.0 P/Share
|
|
Sep 03
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,080
-1.29%
|
$77,000
$25.18 P/Share
|
|
Aug 21
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,547
-1.41%
|
$61,128
$24.78 P/Share
|
|
Aug 21
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,005
-7.45%
|
$480,120
$24.68 P/Share
|
|
Aug 20
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
5,806
-1.57%
|
$133,538
$23.67 P/Share
|
|
Aug 20
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,727
-5.02%
|
$39,721
$23.79 P/Share
|
|
Aug 20
2024
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
2,260
-0.95%
|
$51,980
$23.79 P/Share
|
|
Aug 20
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,453
-1.74%
|
$56,419
$23.79 P/Share
|
|
Aug 13
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,272
-1.2%
|
$49,984
$22.89 P/Share
|
|
Aug 13
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,337
-1.63%
|
$51,414
$22.89 P/Share
|
|
Jul 01
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,080
-1.26%
|
$67,760
$22.49 P/Share
|
|
Jul 01
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
30,000
-23.36%
|
$660,000
$22.46 P/Share
|
|
Jun 13
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
688
-1.29%
|
$14,448
$21.79 P/Share
|
|
Jun 06
2024
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
1,458
-6.78%
|
$30,618
$21.73 P/Share
|
|
May 31
2024
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+21.73%
|
-
|
|
May 31
2024
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+4.65%
|
-
|
|
May 31
2024
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+0.32%
|
-
|
|
May 31
2024
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+24.21%
|
-
|
|
May 31
2024
|
Steve E. Krognes Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+10.07%
|
-
|
|
May 31
2024
|
Erik Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+25.92%
|
-
|
|
May 31
2024
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+36.95%
|
-
|
|
May 31
2024
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+21.73%
|
-
|
|
May 31
2024
|
Peter S Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,967
+21.73%
|
-
|
|
May 15
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,674
-1.42%
|
$33,480
$20.39 P/Share
|
|
Apr 15
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.39%
|
$29,988
$18.29 P/Share
|
|
Apr 01
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
92,500
-66.15%
|
$1,850,000
$20.5 P/Share
|